Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AXL Is a Potential Target for the Treatment of Intestinal Fibrosis
Calen A. Steiner, Eva S. Rodansky, Laura A. Johnson, et al.
Inflammatory Bowel Diseases (2020) Vol. 27, Iss. 3, pp. 303-316
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Revisiting fibrosis in inflammatory bowel disease: the gut thickens
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 3, pp. 169-184
Closed Access | Times Cited: 145
Charting human development using a multi-endodermal organ atlas and organoid models
Qianhui Yu, Umut Kilik, Emily M. Holloway, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3281-3298.e22
Open Access | Times Cited: 117
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Jie Wang, Sinan Lin, J. Mark Brown, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 211-227
Open Access | Times Cited: 78
Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease
Giovanni Santacroce, Marco Vincenzo Lenti, Antonio Di Sabatino
Cells (2022) Vol. 11, Iss. 3, pp. 429-429
Open Access | Times Cited: 47
Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis
Calen A. Steiner, Ian M. Cartwright, Cormac T. Taylor, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 3, pp. C866-C878
Open Access | Times Cited: 25
Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients
Manuela Rizzi, Stelvio Tonello, Davide D’Onghia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 951-951
Open Access | Times Cited: 15
Targeting Diverse Wounds and Scars: Recent Innovative Bio‐design of Microneedle Patch for Comprehensive Management
Z. Zhuang, Yong Wang, Zi‐Xuan Feng, et al.
Small (2023) Vol. 20, Iss. 18
Closed Access | Times Cited: 15
Mechanisms and therapeutic research progress in intestinal fibrosis
Yanjiang Liu, Tao Zhang, Kejian Pan, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges
Joseph Sleiman, Sara El Ouali, Taha Qazi, et al.
Expert Review of Gastroenterology & Hepatology (2020) Vol. 15, Iss. 4, pp. 401-411
Open Access | Times Cited: 37
Preventing fibrosis in IBD: update on immune pathways and clinical strategies
Jie Wang, Bo Yang, Jyotsna Chandra, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 727-734
Closed Access | Times Cited: 4
m6A reader YTHDF1 promotes cardiac fibrosis by enhancing AXL translation
Han Wu, Weitao Jiang, Ping Pang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 499-515
Closed Access | Times Cited: 4
Inflammation accelerating intestinal fibrosis: from mechanism to clinic
Shuzi Xin, Xiaohui Liu, Chengwei He, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and Fibrosis
Leonidas Kandilogiannakis, Eirini Filidou, Ioannis Drygiannakis, et al.
Stem Cells International (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 23
Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements
Shadi Ghorbanzadeh, Javad Yaghmoorian Khojini, Reza Abouali, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells
Hannah Estrada, Shachi Patel, Shervin Rabizadeh, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 5, pp. 667-679
Open Access | Times Cited: 19
Prospective therapeutics for intestinal and hepatic fibrosis
Xin Li, Mengli Yu, Qingwei Zhao, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 8
Efferocytosis in multisystem diseases (Review)
Yifan Zhang, Yiru Wang, Jie Ding, et al.
Molecular Medicine Reports (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 17
Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease
Ioannis Drygiannakis, George Kolios, Eirini Filidou, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 9, pp. 1604-1618
Closed Access | Times Cited: 2
The TNFΔARE Mouse as a Model of Intestinal Fibrosis
Calen A. Steiner, Samuel D. Koch, Tamara Evanoff, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 8, pp. 1013-1028
Open Access | Times Cited: 6
EMILIN-1 deficiency promotes chronic inflammatory disease through TGFβ signaling alteration and impairment of the gC1q/α4β1 integrin interaction
Eliana Pivetta, Alessandra Capuano, Maddalena Vescovo, et al.
Matrix Biology (2022) Vol. 111, pp. 133-152
Open Access | Times Cited: 9
Intestinal stricture in Crohn's disease: A 2020 update
Xiaoxuan Lin, Yun Qiu, Xiao Jun Zhuang, et al.
Journal of Digestive Diseases (2021) Vol. 22, Iss. 7, pp. 390-398
Closed Access | Times Cited: 12
Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model
Laura A. Johnson, Eva S. Rodansky, Anhdao Tran, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 2, pp. 161-175
Open Access | Times Cited: 11
Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2
Nancy G. Casanova, Vivian Reyes-Hernon, Taylor Gregory, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
An organoid and multi-organ developmental cell atlas reveals multilineage fate specification in the human intestine
Qianhui Yu, Umut Kilik, Emily M. Holloway, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 11
Choosing the right biologic for complications of inflammatory bowel disease
Shana Rakowsky, Konstantinos Papamichael, Adam S. Cheifetz
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 3, pp. 235-249
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top